Stockreport

Third Arc Bio Announces $52M Series A Extension to Expand Oncology and Immunology & Inflammation Portfolio [Yahoo! Finance]

T. Rowe Price Group, Inc.  (TROW) 
Last t. rowe price group, inc. earnings: 4/28 07:30 am Check Earnings Report
US:NASDAQ Investor Relations: trow.client.shareholder.com
PDF Omega Funds; additional investors include Life Sciences at Goldman Sachs Alternatives, BVF Partners LP, funds managed by abrdn. Inc., accounts advised by T. Rowe Price A [Read more]